Literature DB >> 3632696

Dissociation of recombinant tumor necrosis factor-alpha studied by gel permeation chromatography.

L O Narhi, T Arakawa.   

Abstract

The structure of tumor necrosis factor-alpha (TNF-alpha) was studied using gel permeation chromatography. At an initial protein concentration of 0.4 mg/ml, the TNF-alpha exists as a compact trimer with a Stokes radius of 2.3 +/- 0.1 nm. This trimer dissociates as the protein concentration is decreased, and this dissociation is effected by pH. At the lower protein concentrations at pH 6.0 a species with a Stokes radius of 1.9 +/- 0.1 nm, possibly monomer, is evident. This species is not obvious at pH 7.0, but instead a species with a Stokes radius of 2.2 +/- 0.1 nm appears.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3632696     DOI: 10.1016/0006-291x(87)90992-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition.

Authors:  Ying Li; Anthony W Frei; Ethan Y Yang; Irayme Labrada-Miravet; Chuqiao Sun; Yanan Rong; Magdalena M Samojlik; Allison L Bayer; Cherie L Stabler
Journal:  Biomaterials       Date:  2020-06-15       Impact factor: 12.479

2.  Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.

Authors:  N S Postma; R C Hermsen; D J Crommelin; W M Eling; J Zuidema
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  The limited proteolysis of tumor necrosis factor-alpha.

Authors:  L O Narhi; M F Rhode; P Hunt; T Arakawa
Journal:  J Protein Chem       Date:  1989-10

4.  Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

Authors:  D Aderka; H Engelmann; Y Maor; C Brakebusch; D Wallach
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

5.  Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases.

Authors:  Jee Un Lee; Woori Shin; Ji Young Son; Ki-Young Yoo; Yong-Seok Heo
Journal:  Int J Mol Sci       Date:  2017-01-23       Impact factor: 5.923

Review 6.  Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis.

Authors:  Heejin Lim; Sang Hyung Lee; Hyun Tae Lee; Jee Un Lee; Ji Young Son; Woori Shin; Yong-Seok Heo
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

7.  A System for Analog Control of Cell Culture Dynamics to Reveal Capabilities of Signaling Networks.

Authors:  Chaitanya S Mokashi; David L Schipper; Mohammad A Qasaimeh; Robin E C Lee
Journal:  iScience       Date:  2019-08-08

8.  MCO Membranes: Enhanced Selectivity in High-Flux Class.

Authors:  Adriana Boschetti-de-Fierro; Manuel Voigt; Markus Storr; Bernd Krause
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

9.  Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange.

Authors:  Karin A van Schie; Pleuni Ooijevaar-de Heer; Lisanne Dijk; Simone Kruithof; Gertjan Wolbink; Theo Rispens
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

10.  Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity.

Authors:  T Masegi; A Kato; K Kitai; M Fukuoka; H Ogawa; Y Ichikawa; S Nakamura; N Watanabe; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.